| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
ASTHMA |
1 Department of General Practice, University of Glasgow, Glasgow, UK
2 Department of Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK
3 Department of Respiratory Medicine, University of Glasgow, Glasgow, UK
Correspondence to:
Correspondence to:
Professor N C Thomson
Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, Western Infirmary, Glasgow G11 6NT UK; n.c.thomson{at}clinmed.gla.ac.uk
Background: Cigarette smokers with asthma are insensitive to short term inhaled corticosteroid therapy, but efficacy when given for a longer duration at different doses is unknown.
Methods: Ninety five individuals with mild asthma were recruited to a multicentre, randomised, double blind, parallel group study comparing inhaled beclomethasone in doses of 400 µg or 2000 µg daily for 12 weeks in smokers and non-smokers. The primary end point was the change in morning peak expiratory flow (PEF). Secondary end points included evening PEF, use of reliever inhaler, number of asthma exacerbations, spirometric parameters, and asthma control score.
Results: After 12 weeks of inhaled beclomethasone there was a considerable difference between the morning PEF measurements of smokers and non-smokers with asthma (–18 (95% CI –35 to –1), adjusted p = 0.035). Among those receiving 400 µg daily there was a difference between the mean (95% CI) morning PEF (l/min) in smokers and non-smokers (–25 (95% CI –45 to –4), adjusted p = 0.019) and in the number of asthma exacerbations (6 v 1 in smokers and non-smokers, respectively, p = 0.007). These differences were reduced between smokers and non-smokers receiving 2000 µg inhaled beclomethasone daily.
Conclusions: Compared with non-smokers, smokers with mild persistent asthma are insensitive to the therapeutic effect of low dose inhaled corticosteroid treatment administered for a 12 week period. The disparity of the response between smokers and non-smokers appears to be reduced with high dose inhaled corticosteroid. These findings have important implications for the management of individuals with mild asthma who smoke.
Abbreviations: FEV1, forced expiratory volume in 1 second; PEF, peak expiratory flow
Keywords: asthma; corticosteroid resistance; smoking; corticosteroid dosage
Relevant Article
Thorax 2005 60: 263.
This article has been cited by other articles:
|
|
 |
|
  S. Holgate, H. Bisgaard, L. Bjermer, T. Haahtela, J. Haughney, R. Horne, A. McIvor, S. Palkonen, D. B. Price, M. Thomas, et al. The Brussels Declaration: the need for change in asthma management Eur. Respir. J., December 1, 2008; 32(6): 1433 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Pinnock A man with poorly controlled asthma and exercise induced symptoms BMJ, October 22, 2008; 337(oct22_2): a1963 - a1963. [Full Text]
|
|
|
|
 |
|
 S E Marsh, J Travers, M Weatherall, M V Williams, S Aldington, P M Shirtcliffe, A L Hansell, M R Nowitz, A A McNaughton, J B Soriano, et al. Proportional classifications of COPD phenotypes Thorax, September 1, 2008; 63(9): 761 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Braganza, R. Chaudhuri, and N. C. Thomson Review: Treating patients with respiratory disease who smoke Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 95 - 107. [Abstract] [PDF]
|
|
|
|
|
|
K. R. Chapman, L. P. Boulet, R. M. Rea, and E. Franssen Suboptimal asthma control: prevalence, detection and consequences in general practice Eur. Respir. J., February 1, 2008; 31(2): 320 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Lee, T. Haselkorn, L. Borish, L. Rasouliyan, B. E. Chipps, and S. E. Wenzel Risk Factors Associated With Persistent Airflow Limitation in Severe or Difficult-to-Treat Asthma: Insights From the TENOR Study Chest, December 1, 2007; 132(6): 1882 - 1889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Kroon Drug interactions with smoking Am. J. Health Syst. Pharm., September 15, 2007; 64(18): 1917 - 1921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Morice, G. A. Fontana, M. G. Belvisi, S. S. Birring, K. F. Chung, P. V. Dicpinigaitis, J. A. Kastelik, L. P. McGarvey, J. A. Smith, M. Tatar, et al. ERS guidelines on the assessment of cough Eur. Respir. J., June 1, 2007; 29(6): 1256 - 1276. [Full Text] [PDF]
|
|
|
|
|
|
S. O Shaheen, R. B Newson, M. P Rayman, A. P-L Wong, M. K Tumilty, J. M Phillips, J. F Potts, F. J Kelly, P. T White, and P. G J Burney Randomised, double blind, placebo-controlled trial of selenium supplementation in adult asthma Thorax, June 1, 2007; 62(6): 483 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. C. Thomson Smokers with Asthma: What Are the Management Options? Am. J. Respir. Crit. Care Med., April 15, 2007; 175(8): 749 - 750. [Full Text] [PDF]
|
|
|
|
|
|
S. C. Lazarus, V. M. Chinchilli, N. J. Rollings, H. A. Boushey, R. Cherniack, T. J. Craig, A. Deykin, E. DiMango, J. E. Fish, J. G. Ford, et al. Smoking Affects Response to Inhaled Corticosteroids or Leukotriene Receptor Antagonists in Asthma Am. J. Respir. Crit. Care Med., April 15, 2007; 175(8): 783 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Barnes Spoilt for Choice? Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 208 - 209. [Full Text] [PDF]
|
|
|
|
|
|
E. Livingston, R. Chaudhuri, A. D. McMahon, I. Fraser, C. P. McSharry, and N. C. Thomson Systemic sensitivity to corticosteroids in smokers with asthma Eur. Respir. J., January 1, 2007; 29(1): 64 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Chaudhuri, E. Livingston, A. D. McMahon, J. Lafferty, I. Fraser, M. Spears, C. P. McSharry, and N. C. Thomson Effects of Smoking Cessation on Lung Function and Airway Inflammation in Smokers with Asthma Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Bush Coughs and wheezes spread diseases: but what about the environment? Thorax, May 1, 2006; 61(5): 367 - 369. [Full Text] [PDF]
|
|
|
|
|
|
S. E. Wenzel and R. Covar Update in asthma 2005. Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 698 - 706. [Full Text] [PDF]
|
|
|
|
|
|
C. Russo, F. D'Angelo, and R. Polosa Study of Infliximab Treatment in Smokers with COPD: What Next? Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1607 - 1608. [Full Text] [PDF]
|
|
|
|
|
|
Spoken sessions Thorax, December 1, 2005; 60(suppl_2): ii4 - ii52. [Full Text] [PDF]
|
|
|
|
|
|
H. Marcovitch What's new this month in BMJ Journals BMJ, May 21, 2005; 330(7501): 1174 - 1174. [Full Text] [PDF]
|
|
|
|
|
|
Minerva BMJ, April 16, 2005; 330(7496): 914 - 914. [Full Text] [PDF]
|
|
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
